HCG Stock Overview Provides medical and healthcare services focusing on cancer and fertility in India and internationally. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
HealthCare Global Enterprises Limited Competitors Price History & Performance
Summary of share price highs, lows and changes for HealthCare Global Enterprises Historical stock prices Current Share Price ₹531.30 52 Week High ₹548.00 52 Week Low ₹314.00 Beta 0.29 1 Month Change 13.40% 3 Month Change 27.53% 1 Year Change 44.49% 3 Year Change 132.47% 5 Year Change 417.08% Change since IPO 210.70%
Recent News & Updates
KKR Reportedly Close to Buying HCG Dec 05
Price target increased by 9.0% to ₹473 Nov 13
HealthCare Global Enterprises Limited Just Missed Earnings - But Analysts Have Updated Their Models Nov 13
Second quarter 2025 earnings: EPS misses analyst expectations Nov 12
HealthCare Global Enterprises Limited Announces the Resignation of Mr. Jeyandran Venugopal as from the Board and Member of Nomination and Remuneration Committee and Corporate Social Responsibility Committee of the Board Nov 09
HealthCare Global Enterprises Limited to Report Q2, 2025 Results on Nov 09, 2024 Oct 24 See more updates
KKR Reportedly Close to Buying HCG Dec 05
Price target increased by 9.0% to ₹473 Nov 13
HealthCare Global Enterprises Limited Just Missed Earnings - But Analysts Have Updated Their Models Nov 13
Second quarter 2025 earnings: EPS misses analyst expectations Nov 12
HealthCare Global Enterprises Limited Announces the Resignation of Mr. Jeyandran Venugopal as from the Board and Member of Nomination and Remuneration Committee and Corporate Social Responsibility Committee of the Board Nov 09
HealthCare Global Enterprises Limited to Report Q2, 2025 Results on Nov 09, 2024 Oct 24
HealthCare Global Enterprises Limited (NSEI:HCG) completed the acquisition of 51% stake in Vizag Hospital and Cancer Research Centre Private Limited. Oct 03
We Take A Look At Why HealthCare Global Enterprises Limited's (NSE:HCG) CEO Compensation Is Well Earned Sep 19 HealthCare Global Enterprises Limited, Annual General Meeting, Sep 25, 2024 Sep 03
Consensus EPS estimates fall by 16%, revenue upgraded Aug 15
First quarter 2025 earnings released: EPS: ₹0.87 (vs ₹0.55 in 1Q 2024) Aug 09
HealthCare Global Enterprises Limited to Report Q1, 2025 Results on Aug 08, 2024 Jul 25
HealthCare Global Enterprises Limited (NSEI:HCG) entered into share purchase agreement to acquire 51% stake in Vizag Hospital and Cancer Research Centre Private Limited for INR 2.1 billion. Jun 28
HealthCare Global Enterprises Limited to Report Q4, 2024 Results on May 29, 2024 May 17
Temasek May Bid for CVC's 60% Stake in Healthcare Global May 04
EQT, TPG and KKR Reportedly Eye Majority Stake in HCG Feb 20
New major risk - Financial position Feb 11
HealthCare Global Enterprises Limited Just Missed EPS By 79%: Here's What Analysts Think Will Happen Next Feb 11
Third quarter 2024 earnings: EPS and revenues miss analyst expectations Feb 09
HealthCare Global Enterprises Limited to Report Q3, 2024 Results on Feb 08, 2024 Jan 18
Consensus EPS estimates fall by 16% Nov 16
Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind Nov 10
HealthCare Global Enterprises Limited to Report Q2, 2024 Results on Nov 09, 2023 Oct 28
HealthCare Global Enterprises Limited (NSEI:HCG) completed the acquisition of Radiation Business from Amrish Oncology Services Private Limited. Oct 06
HealthCare Global Enterprises Limited (NSEI:HCG) completed the acquisition of Oncology Business from SRJ Health Care Private Limited. Oct 05 CVC Capital Mulls Selling Stake in HealthCare Global Enterprises Sep 27
We Think Shareholders Will Probably Be Generous With HealthCare Global Enterprises Limited's (NSE:HCG) CEO Compensation Sep 14
A Look At The Fair Value Of HealthCare Global Enterprises Limited (NSE:HCG) Sep 05
HealthCare Global Enterprises Limited, Annual General Meeting, Sep 20, 2023 Aug 30
HealthCare Global Enterprises Limited (NSEI:HCG) completed the acquisition of Nagpur Cancer Hospital & Research Institute Private Limited from Ajay Mehta, Suchitra Mehta and other shareholders. Aug 23 HealthCare Global Enterprises Limited Announces CFO Changes Aug 19
Consensus EPS estimates increase by 12% Aug 17
New major risk - Financial position Aug 12 HealthCare Global Enterprises Limited (NSEI:HCG) executed business transfer agreement to acquire Radiation Business from Amrish Oncology Services Private Limited for INR 160 million.
First quarter 2024 earnings: EPS misses analyst expectations Aug 11
HealthCare Global Enterprises Limited to Report Q1, 2024 Results on Aug 10, 2023 Jul 29 HealthCare Global Enterprises Limited (NSEI:HCG) entered into a share purchase agreement to acquire Nagpur Cancer Hospital & Research Institute Private Limited from Ajay Mehta, Suchitra Mehta and other shareholders for approximately INR 140 million. Jul 07
Executive Chairman recently sold ₹1.1b worth of stock Jun 04
Full year 2023 earnings: EPS misses analyst expectations May 30
Consensus EPS estimates fall by 11% May 29
HealthCare Global Enterprises Limited's (NSE:HCG) Business Is Yet to Catch Up With Its Share Price May 17
HealthCare Global Enterprises Limited to Report Q4, 2023 Results on May 25, 2023 May 13
Insider recently sold ₹794k worth of stock Apr 02
Insider recently sold ₹1.7m worth of stock Mar 15
Insider recently sold ₹2.9m worth of stock Feb 24
Third quarter 2023 earnings: EPS and revenues miss analyst expectations Feb 10
HealthCare Global Enterprises Limited to Report Q3, 2023 Results on Feb 09, 2023 Jan 25
Insider recently sold ₹846k worth of stock Jan 01
Insider recently sold ₹332k worth of stock Dec 07
High number of new and inexperienced directors Nov 16
Second quarter 2023 earnings released: EPS: ₹0.53 (vs ₹8.22 in 2Q 2022) Nov 13
HealthCare Global Enterprises Limited to Report Q2, 2023 Results on Nov 10, 2022 Nov 01
HealthCare Global Enterprises Limited, Annual General Meeting, Sep 29, 2022 Sep 08
HealthCare Global Enterprises Limited, Annual General Meeting, Sep 29, 2022 Sep 07
Price target decreased to ₹350 Aug 20
First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Aug 11
HealthCare Global Enterprises Limited to Report Q1, 2023 Results on Aug 10, 2022 Jul 29
Executive Chairman recently sold ₹500m worth of stock Jul 04
HealthCare Global Enterprises Limited (BSE:539787) agreed to acquire Radiation therapy centre of Radiant Hospital Services Private Limited from Radiant Hospitality Services Private Limited for INR 160 million. Jun 24
Does HealthCare Global Enterprises (NSE:HCG) Have A Healthy Balance Sheet? Jun 24
Now 21% undervalued Jun 13
Shareholders Shouldn’t Be Too Comfortable With HealthCare Global Enterprises' (NSE:HCG) Strong Earnings Jun 03
Price target increased to ₹377 May 30
Full year 2022 earnings: EPS exceeds analyst expectations May 29
Price target increased to ₹293 May 20
HealthCare Global Enterprises Limited to Report Fiscal Year 2022 Results on May 26, 2022 May 14
High number of new and inexperienced directors Apr 27
Insider recently sold ₹719k worth of stock Mar 10
Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Feb 13
Healthcare Global Enterprises Limited Announces Board Appointments Feb 11
Is HealthCare Global Enterprises (NSE:HCG) Using Too Much Debt? Dec 08
Non-Executive Independent Director Shanker Annaswamy has left the company Dec 05
Price target increased to ₹266 Nov 23
Second quarter 2022 earnings released: EPS ₹8.22 (vs ₹1.94 loss in 2Q 2021) Nov 15
Insider recently sold ₹1.2m worth of stock Sep 23 HealthCare Global Enterprises Limited (BSE:539787) agreed to acquire Hospital Lab Management and Clinical Research Site Management units of Strand Life Sciences.
First quarter 2022 earnings released: ₹0.76 loss per share (vs ₹4.48 loss in 1Q 2021) Aug 13
High number of new directors Aug 01
What Does HealthCare Global Enterprises Limited's (NSE:HCG) Share Price Indicate? Jun 25
Price target increased to ₹196 Jun 21
Full year 2021 earnings released: ₹17.02 loss per share (vs ₹12.05 loss in FY 2020) Jun 20
Non-Executive Independent Director Bhushani Kumar has left the company Jun 04
Non- Independent Non-Executive Director has left the company Apr 04
Insider Buying: The HealthCare Global Enterprises Limited (NSE:HCG) Executive Chairman Just Bought ₹2.4m Worth Of Shares Mar 14
Executive Chairman recently bought ₹2.4m worth of stock Mar 14
New 90-day high: ₹178 Mar 08
The HealthCare Global Enterprises (NSE:HCG) Share Price Is Up 51% And Shareholders Are Holding On Mar 03
Earnings beat expectations, revenue disappoints Feb 14
Third quarter 2021 earnings released: ₹2.33 loss per share (vs ₹2.57 loss in 3Q 2020) Feb 14
HealthCare Global Enterprises Limited Announces Board Changes Feb 13
Price target raised to ₹166 Feb 12 Healthcare Global Enterprises Limited Announces Chief Executive Officer Changes Shareholder Returns HCG IN Healthcare IN Market 7D 7.0% -1.3% -4.2% 1Y 44.5% 41.8% 19.1%
See full shareholder returns
Return vs Market: HCG exceeded the Indian Market which returned 19.1% over the past year.
Price Volatility Is HCG's price volatile compared to industry and market? HCG volatility HCG Average Weekly Movement 4.3% Healthcare Industry Average Movement 5.7% Market Average Movement 6.2% 10% most volatile stocks in IN Market 9.0% 10% least volatile stocks in IN Market 4.1%
Stable Share Price: HCG has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: HCG's weekly volatility (4%) has been stable over the past year.
About the Company HealthCare Global Enterprises Limited, together with its subsidiaries, provides medical and healthcare services focusing on cancer and fertility in India and internationally. The company offers cancer diagnosis and treatment services through radiation therapy, medical oncology, and surgery; and fertility treatment services, including reproductive medicine, assisted reproduction, gynecological endoscopy, and fertility preservation under the Milann brand. It also operates multi-specialty hospitals under the HCG brand that provides inpatient and outpatients treatments with specialties in cardiology, neurology, orthopaedics, gastroenterology, urology, internal medicine and pulmonary, and critical care.
Show more HealthCare Global Enterprises Limited Fundamentals Summary How do HealthCare Global Enterprises's earnings and revenue compare to its market cap? HCG fundamental statistics Market cap ₹74.04b Earnings (TTM ) ₹570.45m Revenue (TTM ) ₹20.44b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) HCG income statement (TTM ) Revenue ₹20.44b Cost of Revenue ₹9.46b Gross Profit ₹10.98b Other Expenses ₹10.41b Earnings ₹570.45m
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/21 20:23 End of Day Share Price 2024/12/20 00:00 Earnings 2024/09/30 Annual Earnings 2024/03/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources HealthCare Global Enterprises Limited is covered by 20 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Candice Pereira Anand Rathi Shares and Stock Brokers Limited Kripashankar Maurya Choice Equity Broking Private Limited Deepika Murarka Choice Equity Broking Private Limited
Show 17 more analysts 
